News | Cardiac Imaging | September 01, 2015

Pie Medical Imaging Recognized for Innovation in Quantitative Cardiovascular Software

Company receives European award for technology leadership from Frost & Sullivan

Pie Medical Imaging, Frost & Sullivan, technology leadership, CAAS, cardiovascular diagnostics

CAAS MRV is part of Pie Medical Imaging's suite of imaging solutions for quantitative cardiovascular diagnosis and treatment planning.

September 1, 2015 — Based on its recent analysis of the cardiovascular image management market, Frost & Sullivan recognizes Pie Medical Imaging (PMI) with the 2015 European Frost & Sullivan Award for Technology Leadership. The Netherlands-based PMI has designed innovative and easy-to-use imaging solutions — its CAAS and 3mensio product lines — which deliver precise and reproducible quantitative results for cardiovascular diagnosis and treatment planning. By improving the quality of cardiovascular diagnostics and interventions, the software is effectually facilitating next-generation research on the efficacy of novel intervention methods.

Among existing imaging modalities, cardiovascular magnetic resonance imaging (CMR) plays a role of growing importance in the assessment of patients with heart failure (HF). Currently, it is difficult to study the myocardial perfusion status in HF due to left ventricular (LV) remodeling and wall thinning, coexistent scars and respiratory artefacts. There is an urgent need for state-of-the-art imaging modalities with software algorithms to diagnose cardiovascular diseases accurately and at an early stage. In response to this need, PMI developed CAAS MRV, a sophisticated software that provides quantitative analyses of cardiovascular magnetic resonance images.

Left and right ventricular analysis from CMR datasets and blood flow measurements from velocity-encoded MR will assist the medical specialist in selecting the best treatment options. For flow analysis, PMI offers CAAS MR Flow and recently released its highly innovative CAAS MR 4D Flow to complete its CMR analysis portfolio.

During interventional procedures, as performed in the catheterization laboratory under X-ray guidance, other analysis tools are required. "Unlike visual estimations of coronary artery dimensions, CAAS QCA automatically determines stenosis severity, which refines the visual estimate and provides objective and reproducible measurements of several important features of the coronary anatomy," said Frost & Sullivan Industry Analyst Darshana De. "To develop the CAAS platform further, PMI has more than 60 full-time R&D resources dedicated to developing and optimizing the advanced visualization and analysis software."

PMI is the market leader in cardiovascular analysis software for cardiology and radiology. Its CAAS and 3mensio brands offer a broad range of products for the analysis of X-ray, MRI, computed tomography (CT), optical coherence tomography (OCT) and intravascular ultrasound (IVUS) images. Its unique products provide:

  • Aortic regurgitation analysis based on X-ray angiography for use in aortic valve replacement procedures (CAAS A-valve);
  • Vessel analysis from MR datasets for research, including bifurcation analysis, vessel wall determination and plaque composition analysis (CAAS MRA);
  • Pre-op planning software for aortic valve, mitral valve and left atrial appendage interventions based on CT imaging (3mensio Structural Heart);
  • Abdominal aneurysm repair (EVAR) analysis software based on CT imaging (3mensio Vascular); and
  • 3-D coronary reconstruction and analysis from two X-ray projections (CAAS QCA3D).

PMI has close ties with research institutions in Europe, the United States, Japan and Australia. These partnerships include evaluation studies and co-development of products and solutions. It also works with core labs such as CRF, New York and Cardialysis in Rotterdam to study the efficacy of new treatment methods.

"PMI's CAAS Workstation is a stand-alone modular software product for the viewing and quantification of X-ray angiographic images and runs on a standard personal computer," noted De. "Its quantitative analyses results are based on semi-automatic contour detection forms and can be exported in various formats across different consoles, independent of the type of vendor acquisition equipment."

The CAAS Workstation offers segmentation of different cardiovascular structures, 3-D reconstruction of vessel segments based on two X-ray projections, as well as measurement and reporting tools. It aids in calculating the dimensions of cardiovascular structures, quantifying stenosis in coronary and peripheral vessels, the motion quantification of left and right ventricular walls, as well as stent visualization and dimension measurement.

For more information: www.piemedicalimaging.com

Related Content

Mayo Clinic Installing First FDA-Approved Clinical 7T MRI
News | Magnetic Resonance Imaging (MRI) | October 20, 2017
Mayo Clinic in Rochester, Minn., will have the first clinical 7-Tesla magnetic resonance imaging (MRI) scanner in North...
Median Technologies Brings iBiopsy Platform to The Liver Meeting
News | Advanced Visualization | October 20, 2017
October 20, 2017 — Median Technologies announced that it will participate in The Liver Meeting, the annual meeting of
Appropriate Use Criteria Published for Valvular Heart Disease Imaging Tests
News | Clinical Decision Support | October 16, 2017
The American College of Cardiology (ACC), along with several partnering societies, recently released appropriate use...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
FDA Clears Siemens Magnetom Terra 7T MRI Device

FDA Clears Siemens Magnetom Terra 7T MRI Device

Technology | Magnetic Resonance Imaging (MRI) | October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
ACR Appropriateness Criteria Add Topics, Increase Diagnostic Imaging Clinical Scenarios
News | Clinical Decision Support | October 11, 2017
October 11, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the...
Guerbet to Participate in French Interventional Radiology Conference
News | Contrast Media | October 10, 2017
Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Overlay Init